reidrubsamen

5 ms·

1. 1.▲
   by reidrubsamen 13y ago

   We are setting up an open science web site within the next few weeks that will update people on the project on a regular basis. We are exploring options for rapid publication including ways to post our work during the review process. If y
2. 2.▲
   by reidrubsamen 13y ago

   Thanks for your comments! We have a great team with a lot of experience in computer science, drug delivery and HIV-relevant lab immunology. I studied biochemistry and computer science at UC Berkeley - then going to Stanford for an MD and M
3. 3.▲
   by reidrubsamen 13y ago

   We as physician scientists never really learned how to communicate science broadly to the public - I think our open science approach, which will bring people close to what we are doing in the lab, is the best way to go! This is a learning
4. 4.▲
   by reidrubsamen 13y ago

   Hi! This is Reid, CEO of immunity project. Thanks for your comments! Our previous work is under review by a PRJ - our crowd funding is allowing us to do additional work which we will try to publish as quickly as possible! We have our whit
5. 5.▲
   by reidrubsamen 13y ago

   Sorry for the delay! It is certainly an interesting application and one that I am personally very interested in pursuing at some point. For now we are focusing on the preventative potential of this new vaccine concept.
6. 6.▲
   by reidrubsamen 13y ago

   Great comments! We expect the beneficial targets to be HLA restricted. We need to do more work to understand if any one individual needs to hit two targets - we think right now that a "master vaccine" would need to contain multi
7. 7.▲
   by reidrubsamen 13y ago

   Thanks very much for the kind note! I would be happy to send you a link to the paper the guys working on the statistical analysis of beneficial HIV target regions when it is published.
8. 8.▲
   by reidrubsamen 13y ago

   Thanks for the question! PLGA is the one of the most commonly implanted biodegradable materials in the world - primarily because it is used is used in dissolving suture (check out this link to very popular PLGA based suture material). Asto
9. 9.▲
   by reidrubsamen 13y ago

   This sounds really interesting! Let me talk to my team. I would love to discuss this with you further. Please email me at team@immunityproject.org
10. 10.▲
    by reidrubsamen 13y ago

    Thanks for the comment! We did not mean to imply that existing vaccines were dangerous and will modify the language on the site to clarify.
11. 11.▲
    by reidrubsamen 13y ago

    Hi there, Reid from Immunity Project. Thanks for the great question! Would love to talk with you off line about your research, by the way. 1. We have successfully gotten an immune response with memory (by elispot) after a single dose